We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Policy.
Home » Topics » NSC Alcohol, Drugs and Impairment Division news
Gaithersburg, MD — Researchers at the National Institute of Standards and Technology and the University of Colorado Boulder are partnering to test whether a new breath-test strategy can reliably detect recent cannabis use.
Washington — Federal action aimed at easing restrictions on marijuana under the Controlled Substances Act could jeopardize federally required drug testing for workers in safety-sensitive jobs, the National Transportation Safety Board warns.
Boston — Unintentional overdoses accounted for more than 1 out of 4 workplace deaths in Massachusetts between 2021 and 2022, the state’s Department of Public Health reports.
Denver — Colorado Gov. Jared Polis (D) has signed legislation that includes funding aimed at establishing recovery friendly workplaces and supporting people in recovery from substance use disorders.
San Diego — Opioid use related to workers’ compensation claims decreased nearly 10% in 2023, marking one of the largest drops the workers’ comp industry has seen in years, according to a new report.
Washington — Federal action aimed at easing restrictions on marijuana under the Controlled Substances Act “may have considerable negative consequences for highway safety and safety-sensitive industries,” the American Trucking Associations claims.
Washington — The National Institute of Environmental Health Sciences’ Worker Training Program has published Spanish-language versions of its resources on COVID-19’s impact on mental health and substance use.
Secaucus, NJ — The percentage of U.S. workers whose drug test showed signs of tampering skyrocketed in 2023 to its highest level in over 30 years, according to Quest Diagnostics’ annual Drug Testing Index.
Taking prescription medicines known as “Z-drugs” for insomnia may lead to complex sleep behaviors, overdose, injury and – in rare cases – death, the Food and Drug Administration cautions in a recent alert.